Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CONTINUOUS INTRAVENOUS HEPARIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 125 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Axelrod, DA; Wakefield, TW
      Future directions in antithrombotic therapy: Emphasis on venous thromboembolism

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    2. Di Minno, G; Tufano, A; Cerbone, AM
      Antithrombotic drugs for older subjects - Guidelines formulated jointly bythe Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG)

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    3. Grau, E; Tenias, JM; Real, E; Medrano, J; Ferrer, R; Pastor, E; Selfa, S
      Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism

      AMERICAN JOURNAL OF HEMATOLOGY
    4. Couturaud, F; Julian, JA; Kearon, C
      Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism - A meta-analysis

      THROMBOSIS AND HAEMOSTASIS
    5. Prandoni, P
      Heparins and venous thromboembolism: Current practice and future directions

      THROMBOSIS AND HAEMOSTASIS
    6. Rose, P; Bell, D; Green, ES; Davenports, A; Fegan, C; Grech, H; O'Shaughnessy, D; Voke, J
      The outcome of ambulatory DVT management using a multidisciplinary approach

      CLINICAL AND LABORATORY HAEMATOLOGY
    7. Tait, RC
      Anticoagulation in patients with thromboembolic disease

      THORAX
    8. Egermayer, P
      The effects of heparin and oral anticoagulants on thrombus propagation andprevention of the postphlebitic syndrome: A critical review of the literature

      PROGRESS IN CARDIOVASCULAR DISEASES
    9. Paterson, DI; Schwartzman, K
      Strategies incorporating spiral CT for the diagnosis of acute pulmonary embolism - A cost-effectiveness analysis

      CHEST
    10. Hirsh, J; Warkentin, TE; Shaughnessy, SG; Anand, SS; Halperin, JL; Raschke, R; Granger, C; Ohman, EM; Dalen, JE
      Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

      CHEST
    11. Hyers, TM; Agnelli, G; Hull, RD; Morris, TA; Samama, M; Tapson, V; Weg, JG
      Antithrombotic therapy for venous thromboembolic disease

      CHEST
    12. Hirsh, J; Anand, SS; Halperin, JL; Fuster, V
      Guide to anticoagulant therapy: Heparin a statement for healthcare professionals from the American Heart Association

      CIRCULATION
    13. Bates, SM; Weitz, JI; Johnston, M; Hirsh, J; Ginsberg, JS
      Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin

      ARCHIVES OF INTERNAL MEDICINE
    14. Hirsh, J; Bates, SM
      Clinical trials that have influenced the treatment of venous thromboembolism: A historical perspective

      ANNALS OF INTERNAL MEDICINE
    15. Rose, PE
      Anticoagulant therapy and referral form

      HOSPITAL MEDICINE
    16. Balcezak, TJ; Krumholz, HM; Getnick, GS; Vaccarino, V; Lin, ZQ; Cadman, EC
      Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center

      AMERICAN JOURNAL OF MANAGED CARE
    17. Morris, TA
      Low molecular weight heparins: Background and pharmacology

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    18. Oger, E; Mottier, D
      Update on anticoagulants

      PRESSE MEDICALE
    19. Siguret, V; Pautas, E; Fevrier, M; Wipff, C; Durand-Gasselin, B; Laurent, M; Andreux, JP; d'Urso, M; Gaussem, P
      Elderly patients treated with tinzaparin (Innohep (R)) administered once daily (175 anti-Xa IU/kg): Anti-Xa and anti-IIa activities over 10 days

      THROMBOSIS AND HAEMOSTASIS
    20. Kearon, C; Harrison, L; Crowther, M; Ginsberg, JS
      Optimal dosing of subcutaneous unfractionated heparin for the treatment ofdeep vein thrombosis

      THROMBOSIS RESEARCH
    21. Lobato-Mendizabal, E; Majluf-Cruz, A
      Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins

      REVISTA DE INVESTIGACION CLINICA
    22. Hirsh, J; Bates, SM
      The emerging role of low-molecular-weight heparin in cardiovascular medicine

      PROGRESS IN CARDIOVASCULAR DISEASES
    23. Kitchen, S
      Problems in laboratory monitoring of heparin dosage

      BRITISH JOURNAL OF HAEMATOLOGY
    24. Dolovich, LR; Ginsberg, JS; Douketis, JD; Holbrook, AM; Cheah, G
      A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism - Examining some unanswered questions regarding location of treatment, product type, and dosing frequency

      ARCHIVES OF INTERNAL MEDICINE
    25. Prandoni, P; Mannucci, PM
      Deep-vein thrombosis of the lower limbs: diagnosis and management

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    26. Caps, MT; Meissner, MH; Tullis, MJ; Polissar, NL; Manzo, RA; Zierler, BK; Chandler, WL; Strandness, DE
      Venous thrombus stability during acute phase of therapy

      VASCULAR MEDICINE
    27. Baron, RM; Goldhaber, SZ
      Deep venous thrombosis: Outpatient management is now FDA approved

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    28. Gonzalez-Fajardo, JA; Arreba, E; Castrodeza, J; Perez, JL; Fernandez, L; Agundez, I; Mateo, AM; Carrera, S; Gutierrez, V; Vaquero, C
      Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis

      JOURNAL OF VASCULAR SURGERY
    29. Bates, SM; Hirsh, J
      Treatment of venous thromboembolism

      THROMBOSIS AND HAEMOSTASIS
    30. Eriksson, H; Eriksson, UG; Frison, L; Hansson, PO; Held, P; Holmstrom, M; Hagg, A; Jonsson, T; Lapidus, L; Leijd, B; Stockelberg, D; Safwenberg, U; Taghavi, A; Thorsen, M
      Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMWthrombin inhibitor, in patients with acute DVT

      THROMBOSIS AND HAEMOSTASIS
    31. Grau, E; Real, E; Medrano, J; Pastor, E; Selfa, S
      Recurrent venous thromboembolism in a Spanish population: Incidence, risk factors, and management in a hospital setting

      THROMBOSIS RESEARCH
    32. Zed, PJ; Tisdale, JE; Borzak, S
      Low-molecular-weight heparins in the management of acute coronary syndromes

      ARCHIVES OF INTERNAL MEDICINE
    33. Gould, MK; Dembitzer, AD; Sanders, GD; Garber, AM
      Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A cost-effectiveness analysis

      ANNALS OF INTERNAL MEDICINE
    34. Gould, MK; Dembitzer, AD; Doyle, RL; Hastie, TJ; Garber, AM
      Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A meta-analysis of randomized, controlled trials

      ANNALS OF INTERNAL MEDICINE
    35. HEILMANN L; TEMPELHOFF GFV; SCHNEIDER D
      PREVENTION OF THROMBOSIS IN GYNECOLOGIC MALIGNANCY

      Clinical and applied thrombosis/hemostasis
    36. RACHAKONDA V; RACHAKONDA L; BELLIVEAU RR
      APTT IN HEPARINIZED PATIENTS - INFLUENCE OF THE INTERVAL BETWEEN SAMPLING AND TESTING

      Clinical and applied thrombosis/hemostasis
    37. NEVARRE DR; DIGIOVANNI A
      HYPERCOAGULABILITY AND THE MANAGEMENT OF ANTICOAGULANT-THERAPY IN SURGICAL PATIENTS - REVIEW AND RECOMMENDATIONS

      Journal of endovascular surgery
    38. WHITTLE J; JOHNSON P; LOCALIO AR
      ANTICOAGULATION THERAPY IN PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE

      Journal of general internal medicine
    39. DEGROOT MR; BULLER HR; TENCATE JW; KOOY MV
      USE OF A HEPARIN NOMOGRAM FOR TREATMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM IN A COMMUNITY-HOSPITAL

      Thrombosis and haemostasis
    40. Hull, RD; Pineo, GF; Raskob, GE
      The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: Outcome of therapy and health economy aspects - Low-molecular-weight heparin versus unfractionated heparin

      HAEMOSTASIS
    41. Prandoni, P
      Unfractionated heparin and low-molecular-weight heparin for the initial treatment of acute venous thromboembolism

      HAEMOSTASIS
    42. ROSE PE; FITZMAURICE D
      NEW APPROACHES TO THE DELIVERY OF ANTICOAGULANT SERVICES

      Blood reviews
    43. KEARON C
      LOW-MOLECULAR-WEIGHT HEPARIN VERSUS UNFRACTIONATED HEPARIN FOR UNSTABLE CORONARY-DISEASE

      The New England journal of medicine
    44. PINEO GF; HULL RD
      UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN - COMPARISONS AND CURRENT RECOMMENDATIONS

      The Medical clinics of North America
    45. HIRSH J; WARKENTIN TE; RASCHKE R; GRANGER C; OHMAN EM; DALEN JE
      HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN - MECHANISMS OF ACTION, PHARMACOKINETICS, DOSING CONSIDERATIONS, MONITORING, EFFICACY, AND SAFETY

      Chest
    46. HYERS TM; AGNELLI G; HULL RD; WEG JG; MORRIS TA; SAMAMA M; TAPSON V
      ANTITHROMBOTIC THERAPY FOR VENOUS THROMBOEMBOLIC DISEASE

      Chest
    47. HANSEN JB; SANDSET PM; HUSEBY KR; HUSEBY NE; BENDZ B
      DIFFERENTIAL EFFECT OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN ON INTRAVASCULAR TISSUE FACTOR PATHWAY INHIBITOR - EVIDENCE FOR A DIFFERENCE IN ANTITHROMBOTIC ACTION

      British Journal of Haematology
    48. MUNGALL D
      ACTIVATED PARTIAL THROMBOPLASTIN TIME VS HEPARIN CONCENTRATION

      Archives of internal medicine
    49. BAKER BA; ADELMAN MD
      ACTIVATED PARTIAL THROMBOPLASTIN TIME VS HEPARIN CONCENTRATION - IN REPLY

      Archives of internal medicine
    50. MUNGALL D; LORD M; CASON S; TREADWELL P; WILLIAMS D; TEDRICK D
      DEVELOPING AND TESTING A SYSTEM TO IMPROVE THE QUALITY OF HEPARIN ANTICOAGULATION IN PATIENTS WITH ACUTE CARDIAC SYNDROMES

      The American journal of cardiology
    51. LLOYD AC; AITKEN JA; HOFFMEYER UK; KELSO EJ; WAKERLY EC; BARBER ND
      ECONOMIC-EVALUATION OF THE USE OF NADROPARIN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS IN SWITZERLAND

      The Annals of pharmacotherapy
    52. SCHLICHT JR; SUNYECZ L; WEBER RJ; TABAS GH; SMITH RE
      REEVALUATION OF A WEIGHT-BASED HEPARIN DOSING NOMOGRAM - IS INSTITUTION-SPECIFIC MODIFICATION NECESSARY

      The Annals of pharmacotherapy
    53. ADAMS HP; LEIRA EC
      ACUTE THERAPEUTIC INTERVENTION - ANTITHROMBOTIC AND ANTIPLATELET-AGGREGATING DRUGS

      Neurosurgery clinics of North America
    54. PRANDONI P; VILLALTA S; BAGATELLA P; ROSSI L; MARCHIORI A; PICCIOLI A; BERNARDI E; GIROLAMI B; SIMIONI P; GIROLAMI A
      THE CLINICAL COURSE OF DEEP-VEIN THROMBOSIS - PROSPECTIVE LONG-TERM FOLLOW-UP OF 528 SYMPTOMATIC PATIENTS

      Haematologica
    55. IORIO A; AGNELLI G
      PHARMACOKINETIC OPTIMIZATION OF THE TREATMENT OF DEEP-VEIN THROMBOSIS

      Clinical pharmacokinetics
    56. KHER A; ALDIERI R; HEMKER HC; BEGUIN S
      LABORATORY ASSESSMENT OF ANTITHROMBOTIC THERAPY - WHAT TESTS AND IF SO WHY

      Haemostasis
    57. MONREAL M; URRUTIA A; MARTI S; CUXART A; RONCALES J
      PLATELET COUNT AND THE RISK OF BLEEDING IN HOSPITALIZED-PATIENTS WITHVENOUS THROMBOEMBOLISM STARTING ANTICOAGULANT-THERAPY

      Haemostasis
    58. TOH CH
      ANTICOAGULANTS FOR VENOUS THROMBOSIS

      Postgraduate medical journal
    59. HULL RD; RASKOB GE; BRANT RF; PINEO GF; VALENTINE KA
      RELATION BETWEEN THE TIME TO ACHIEVE THE LOWER LIMIT OF THE APTT THERAPEUTIC RANGE AND RECURRENT VENOUS THROMBOEMBOLISM DURING HEPARIN TREATMENT FOR DEEP-VEIN THROMBOSIS

      Archives of internal medicine
    60. BAKER BA; ADELMAN MD; SMITH PA; OSBORN JC
      INABILITY OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME TO PREDICT HEPARIN LEVELS - TIME TO REASSESS GUIDELINES FOR HEPARIN ASSAYS

      Archives of internal medicine
    61. HULL RD; RASKOB GE; BRANT RF; PINEO GF; VALENTINE KA
      THE IMPORTANCE OF INITIAL HEPARIN TREATMENT ON LONG-TERM CLINICAL OUTCOMES OF ANTITHROMBOTIC THERAPY - THE EMERGING THEME OF DELAYED RECURRENCE

      Archives of internal medicine
    62. MONREAL M; COSTA J; SALVA P
      DRUG-THERAPY - PHARMACOLOGICAL PROPERTIES OF HIRUDIN AND ITS DERIVATIVES - POTENTIAL CLINICAL ADVANTAGES OVER HEPARIN

      Drugs & aging
    63. HULL RD; PINEO GF; BRANT RF
      EFFECT OF LOW-MOLECULAR-WEIGHT HEPARIN VERSUS WARFARIN SODIUM ON MORTALITY IN LONG-TERM TREATMENT OF PROXIMAL VEIN-THROMBOSIS

      Clinical and applied thrombosis/hemostasis
    64. HULL RD; PINEO GF
      LOW-MOLECULAR-WEIGHT HEPARIN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM

      Seminars in respiratory and critical care medicine
    65. SAMAMA M; VALDES JC; NATALI J
      MEDICOLEGAL IMPLICATIONS OF ANTICOAGULANT TREATMENTS

      Journal des maladies vasculaires
    66. VOLTEAS SK; KALODIKI E; NICOLAIDES AN
      LOW-MOLECULAR-WEIGHT HEPARINS IN THE INITIAL TREATMENT OF DEEP-VEIN THROMBOSIS

      International angiology
    67. KITCHEN S; PRESTON FE
      THE THERAPEUTIC RANGE FOR HEPARIN-THERAPY - RELATIONSHIP BETWEEN 6 ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTS AND 2 HEPARIN ASSAYS

      Thrombosis and haemostasis
    68. PARTSCH H
      DIAGNOSIS AND TREATMENT OF DEEP VENOUS TH ROMBOSIS

      VASA
    69. BAGLIN TP
      LOW-MOLECULAR-WEIGHT HEPARINS AND NEW STRATEGIES FOR THE TREATMENT OFPATIENTS WITH ESTABLISHED VENOUS THROMBOSIS

      Haemostasis
    70. BONEU B
      GLYCOSAMINOGLYCANS - CLINICAL USE

      Seminars in thrombosis and hemostasis
    71. HYERS TM
      INTEGRATED MANAGEMENT OF VENOUS THROMBOEMBOLISM

      Southern medical journal
    72. HARENBERG J; HUHLE G; PIAZOLO L; MALSCH R
      THERAPY OF THROMBOSIS - NEW DEVELOPMENTS

      Die medizinische Welt
    73. PINEO GF; HULL RD
      PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

      Drugs
    74. HIRSH J; HOAK J
      MANAGEMENT OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - A STATEMENT FOR HEALTH-CARE PROFESSIONALS - FROM THE COUNCIL ON THROMBOSIS (IN CONSULTATION WITH THE COUNCIL ON CARDIOVASCULAR RADIOLOGY), AMERICAN-HEART-ASSOCIATION

      Circulation
    75. SIRAGUSA S; COSMI B; PIOVELLA F; HIRSH J; GINSBERG JS
      LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN THE TREATMENT OF PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM - RESULTS OF A METAANALYSIS

      The American journal of medicine
    76. HIRSCH DR; LEE TH; MORRISON RB; CARLSON W; GOLDHABER SZ
      SHORTENED HOSPITALIZATION BY MEANS OF ADJUSTED-DOSE SUBCUTANEOUS HEPARIN FOR DEEP VENOUS THROMBOSIS

      The American heart journal
    77. LEVINE MN; HIRSH J; GENT M; TURPIE AG; WEITZ J; GINSBERG J; GEERTS W; LECLERC J; NEEMEH J; POWERS P; PIOVELLA F
      OPTIMAL DURATION OF ORAL ANTICOAGULANT-THERAPY - A RANDOMIZED TRIAL COMPARING 4 WEEKS WITH 3 MONTHS OF WARFARIN IN PATIENTS WITH PROXIMAL DEEP-VEIN THROMBOSIS

      Thrombosis and haemostasis
    78. TENCATE JW; KOOPMAN MMW; PRINS MH; BULLER HR
      TREATMENT OF VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    79. KOOPMAN MMW; BULLER HR; TENCATE JW
      DIAGNOSIS OF RECURRENT DEEP-VEIN THROMBOSIS

      Haemostasis
    80. HULL RD; PINEO GF
      CURRENT CONCEPTS OF ANTICOAGULATION THERAPY

      Clinics in chest medicine
    81. HIRSH J
      HEPARINS

      Fibrinolysis
    82. GIBALDI M; WITTKOWSKY AK
      CONTEMPORARY USE OF AND FUTURE ROLES FOR HEPARIN IN ANTITHROMBOTIC THERAPY

      Journal of clinical pharmacology
    83. BARBOUR LA; PICKARD J
      CONTROVERSIES IN THROMBOEMBOLIC DISEASE DURING PREGNANCY - A CRITICAL-REVIEW

      Obstetrics and gynecology
    84. HIRSH J; RASCHKE R; WARKENTIN TE; DALEN JE; DEYKIN D; POLLER L
      HEPARIN - MECHANISM OF ACTION, PHARMACOKINETICS, DOSING CONSIDERATIONS, MONITORING, EFFICACY, AND SAFETY

      Chest
    85. LEVINE MN; RASKOB G; LANDEFELD S; HIRSH J
      HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT TREATMENT

      Chest
    86. HYERS TM; HULL RD; WEG JG
      ANTITHROMBOTIC THERAPY FOR VENOUS THROMBOEMBOLIC DISEASE

      Chest
    87. AGNELLI G
      ANTICOAGULATION IN THE PREVENTION AND TREATMENT OF PULMONARY-EMBOLISM

      Chest
    88. TYRRELL MR; BIRTLE AJ; TAYLOR PR
      DEEP-VEIN THROMBOSIS

      British journal of clinical practice
    89. BEYTH RJ; COHEN AM; LANDEFELD CS
      LONG-TERM OUTCOMES OF DEEP-VEIN THROMBOSIS

      Archives of internal medicine
    90. SCHIELE F; VUILLEMENOT A; MOUHAT T; KRAMARZ P; KIEFFER Y; CAMEZ A; BASSAND JP
      SUBCUTANEOUS RECOMBINANT HIRUDIN IN THE T REATMENT OF DEEP VENOUS THROMBOSIS - A PHARMACOKINETIC STUDY

      Archives des maladies du coeur et des vaisseaux
    91. NURMOHAMED MT; BULLER HR; TENCATE JW
      PHYSIOLOGICAL-CHANGES DUE TO AGE - IMPLICATIONS FOR THE PREVENTION AND TREATMENT OF THROMBOSIS IN OLDER PATIENTS

      Drugs & aging
    92. LEIZOROVICZ A; SIMONNEAU G; DECOUSUS H; BOISSEL JP
      COMPARISON OF EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN INITIAL TREATMENT OF DEEP VENOUS THROMBOSIS - A METAANALYSIS

      BMJ. British medical journal
    93. PRANDONI P; MANNUCCI PM
      DEEP-VEIN THROMBOSIS OF THE LOWER-LIMBS - DIAGNOSIS AND MANAGEMENT

      Bailliere's clinical haematology
    94. PINEDE L; NINET J; BOISSEL JP; PASQUIER J
      ANTICOAGULANT-THERAPY FOR VENOUS THROMBOE MBOLISM - OPTIMAL DURATION OF ORAL ANTIVITAMIN-K

      La Presse medicale
    95. MEYER G; FARGE D; SAUVAGET F; DIEHL JL; HERVE R; ROUFFY J; SORS H
      THROMBOEMBOLISM AND CANCER

      La Presse medicale
    96. RUBIN BG; REILLY JM; SICARD GA; BOTNEY MD
      CARE OF PATIENTS WITH DEEP VENOUS THROMBOSIS IN AN ACADEMIC-MEDICAL-CENTER - LIMITATIONS AND LESSONS

      Journal of vascular surgery
    97. BOUNAMEAUX H
      HEMORRHAGIC COMPLICATIONS OF THE ANTICOAG ULANT TREATMENTS IN ANGIOLOGY

      Journal des maladies vasculaires
    98. SCHIELE F; VUILLEMENOT A; KRAMARZ P; KIEFFER Y; SORIA J; SORIA C; CAMEZ A; MIRSHAHI MC; BASSAND JP
      A PILOT-STUDY OF SUBCUTANEOUS RECOMBINANT HIRUDIN (HBW-023) IN THE TREATMENT OF DEEP-VEIN THROMBOSIS

      Thrombosis and haemostasis
    99. SARASIN FP; BOUNAMEAUX H
      DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER PROXIMAL DEEP-VEIN THROMBOSIS - A DECISION-ANALYSIS

      Thrombosis and haemostasis
    100. YOUNG E; WELLS P; HOLLOWAY S; WEITZ J; HIRSH J
      EX-VIVO AND IN-VITRO EVIDENCE THAT LOW-MOLECULAR-WEIGHT HEPARINS EXHIBIT LESS BINDING TO PLASMA-PROTEINS THAN UNFRACTIONATED HEPARIN

      Thrombosis and haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 22:06:48